全文获取类型
收费全文 | 5876篇 |
免费 | 247篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 96篇 |
妇产科学 | 24篇 |
基础医学 | 697篇 |
口腔科学 | 70篇 |
临床医学 | 346篇 |
内科学 | 1405篇 |
皮肤病学 | 128篇 |
神经病学 | 399篇 |
特种医学 | 150篇 |
外科学 | 1252篇 |
综合类 | 18篇 |
预防医学 | 173篇 |
眼科学 | 193篇 |
药学 | 450篇 |
中国医学 | 1篇 |
肿瘤学 | 654篇 |
出版年
2022年 | 48篇 |
2021年 | 60篇 |
2020年 | 41篇 |
2019年 | 54篇 |
2018年 | 83篇 |
2017年 | 74篇 |
2016年 | 88篇 |
2015年 | 111篇 |
2014年 | 144篇 |
2013年 | 160篇 |
2012年 | 233篇 |
2011年 | 276篇 |
2010年 | 170篇 |
2009年 | 136篇 |
2008年 | 235篇 |
2007年 | 259篇 |
2006年 | 275篇 |
2005年 | 299篇 |
2004年 | 287篇 |
2003年 | 286篇 |
2002年 | 311篇 |
2001年 | 205篇 |
2000年 | 227篇 |
1999年 | 210篇 |
1998年 | 67篇 |
1997年 | 67篇 |
1996年 | 54篇 |
1995年 | 57篇 |
1994年 | 56篇 |
1993年 | 50篇 |
1992年 | 144篇 |
1991年 | 129篇 |
1990年 | 115篇 |
1989年 | 107篇 |
1988年 | 116篇 |
1987年 | 91篇 |
1986年 | 105篇 |
1985年 | 109篇 |
1984年 | 56篇 |
1983年 | 50篇 |
1982年 | 34篇 |
1981年 | 27篇 |
1979年 | 39篇 |
1977年 | 34篇 |
1974年 | 29篇 |
1973年 | 27篇 |
1972年 | 28篇 |
1969年 | 27篇 |
1967年 | 33篇 |
1966年 | 27篇 |
排序方式: 共有6142条查询结果,搜索用时 15 毫秒
141.
Tadanori Ishikawa Tadashi Horimi Yasuo Shima Takahiro Okabayashi Yutaka Nishioka Madoka Hamada Junichi Ichikawa Atsuhito Tsuji Masahiro Takamatsu Sojiro Morita 《Journal of hepato-biliary-pancreatic sciences》2003,10(3):233-238
Background/Purpose. An aggressive approach is required to resect advanced carcinoma of the gallbladder. Therefore, an extended surgical procedure often brings about a poor surgical outcome. To test whether an aggressive surgical treatment can improve the survival rate for primary advanced carcinoma of the gallbladder, 59 patients with stage IV primary gallbladder carcinoma were studied. Methods. Patients were divided into three treatment groups for the survival analysis: group A (resectional surgery, n = 29), group B (low-dose cis-diamminedichloroplatinum-II and 5-fluorouracil therapy, n = 10), and group C (exploratory laparotomy, other treatment modalities, or no treatment, n = 20). Results. The prognosis of group A patients was significantly better than that of group B (P = 0.018) or group C (P = 0.0009). Furthermore, group A patients were divided into subgroups. The prognosis of patients resected with no distant metastasis (group A1) was significantly better than that of patients resected with distant metastases of the distant lymph nodes and the liver (group A2) (P = 0.0004). Also, there was no significant difference in the survival rate between the patients resected with distant metastasis (group A2) and chemotherapy cases (group B). Conclusions. These results indicated that radical surgery should be performed for patients with no distant metastasis, and that chemotherapy might be a useful alternative treatment for patients with distant metastasis in advanced carcinoma of the gallbladder. 相似文献
142.
AIMS: We recently demonstrated that aldosterone induces a non-genomic vasoconstrictor effect on rat coronary arterioles and that this effect was blocked by angiotensin II type 1 receptor (AT1) blockers. Intracellular transglutaminase enhances AT1 signalling by cross-linking AT1 homodimers. The purpose of this study was to confirm the AT1-dependency of the vasoconstrictor effect of aldosterone using AT1a knockout (AT1aKO) mice and to investigate the role of intracellular transglutaminase and AT1 dimerization in this effect. METHODS AND RESULTS: The mesenteric arterioles (60-160 microm) were isolated from C57BL/6J (wild-type, WT) and AT1aKO mice, and the internal diameter was measured by video microscopy. Aldosterone (10(-13) to 10(-6) M), but not hydrocortisone, produced a dose-dependent vasoconstriction in WT mice; the maximal diameter change was -8.6 +/- 0.3% from the baseline (P < 0.001). This vasoconstrictor effect was unaffected by the mineralocorticoid receptor antagonist spironolactone or eplerenone, the AT2 antagonist PD123319, the glucocorticoid receptor antagonist RU486, or endothelium denudation. Aldosterone's vasoconstrictor effect was negligible in AT1aKO mice. The AT1 blockers valsartan or candesartan suppressed aldosterone-induced vasoconstriction in WT mice. The transglutaminase inhibitors cystamine and monodansyl cadaverine also suppressed the vasoconstrictor effect of aldosterone, without affecting the vasoconstrictor effect of angiotensin II in WT mice. AT1 dimer protein levels were increased in WT mesenteric arterioles treated with 10(-7) M aldosterone, and the transglutaminase inhibitor and AT1 blocker blocked this aldosterone-induced formation of AT1 dimer. Treatment with 10(-7) M aldosterone for 10 min increased the transglutaminase activity by 2.5 +/- 0.2-fold in cultured vascular smooth muscle cells and by 1.2 +/- 0.1-fold in the mesenteric arterioles. These increases were abolished by transglutaminase inhibitors. CONCLUSION: Aldosterone produces a non-genomic, endothelium-independent vasoconstrictor effect by enhancing intracellular transglutaminase activity and presumably inducing AT1 dimer formation in mesenteric arterioles. 相似文献
143.
Masaru Nakayama Haruki Itoh Keiko Oikawa Akihiko Tajima Akira Koike Tadanori Aizawa Long-Tai Fu Fumihiko Miyake 《Circulation journal》2005,69(6):683-687
BACKGROUND: The magnitudes of the first (WI1) and the second wave-intensity peak (WI2) during the ejection period can be used as indices of left ventricular (LV) contractility and relaxation, respectively. However, use of WI to characterize LV dp/dt and the end-diastolic volume (V ed) relationship may be more problematic, as WI may be affected by changes in preload. METHODS AND RESULTS: The LV pressure-volume data sets, consisting of 23 recordings obtained by the conductance method from 12 heart disease patients, were studied. End-systolic elastance (E es) and volume-axis-intercept (V0) were calculated with varying preload. Time constant of LV relaxation (tau), V ed, and WI were calculated from steady-state averaged data. The E es showed a weak correlation with WI1 (r = 0.46, p < 0.05) but a better correlation with preload-adjusted WI1 [WI1/V ed; r=0.86, WI1/V(ed)2; r = 0.92, WI1/(V ed - V0)2; r = 0.89, all p < 0.01]. Similarly, tau did not correlate with WI2 but did correlate with preload-adjusted WI2 [WI2/V ed; r = -0.73, WI2/V(ed) 2; r = -0.63, WI2/(V ed - V0)2; r = -0.78, all p < 0.01]. CONCLUSIONS: These data demonstrate the importance of preload-adjustment when using the WI index for simultaneous assessment of LV contractility and relaxation. 相似文献
144.
Matsumoto K Morishita R Tomita N Moriguchi A Komai N Aoki M Matsumoto K Nakamura T Higaki J Ogihara T 《Heart and vessels》2003,18(1):18-25
Hepatocyte growth factor (HGF) is a unique growth factor with many protective functions. Previously, we demonstrated that
HGF stimulated growth of endothelial cells without replication of vascular smooth muscle cells (VSMC) and that angiotensin
(Ang) II significantly decreased local HGF production in VSMC. Moreover, we also reported that high glucose significantly
decreased local vascular HGF production. Therefore, we examined effects of Ang II blockade on vascular HGF expression and
endothelial injury in diabetic hypertensive rats. An angiotensin-converting enzyme inhibitor (quinapril) and an Ang II type
1 receptor antagonist (GA-0113) or vehicle was administrated to diabetic spontaneously hypertensive rats (SHR-DM), in whom
diabetes was induced by streptozotocin. Endothelial function was evaluated by the vasodilator response to acetylcholine, and
the expression of vascular HGF and its receptor, c-met, was examined by immunohistochemistry. Both quinapril and GA-0113 significantly
improved the vasodilator response to acetylcholine (P < 0.01), while vehicle did not as compared to untreated normotensive Wistar-Kyoto rats (WKY). We next examined the effects
of Ang II blockade on vascular HGF expression in SHR-DM. Importantly, the vascular HGF level was markedly decreased in SHR-DM
as compared to WKY, while Ang II blockade by quinapril or GA-0113 significantly increased positive staining for HGF in SHR-DM.
Similarly, staining of its specific receptor, c-met, was less in the blood vessels of SHR-DM as compared to WKY. In contrast,
Ang II blockade also significantly increased c-met production in SHR-DM. The present data demonstrated the improvement of
endothelial dysfunction by Ang II blockade in SHR-SM, accompanied by an increase in vascular HGF and c-met.
Received: June 7, 2002 / Accepted: September 21, 2002
Acknowledgments We wish to thank Rie Kosai and Keiko Yamaguchi for their excellent technical assistance. This work was partially supported
by grants from the Japan Health Sciences Foundation, a Grant-in-Aid from The Ministry of Public Health and Welfare, a Grant-in-Aid
for the Development of Innovative Technology, a Grant-in-Aid from Japan Promotion of Science, and through Special Coordination
Funds of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government.
Correspondence to N. Tomita 相似文献
145.
146.
Miwa Haruta Yusuke Tomita Yuya Imamura Keiko Matsumura Tokunori Ikeda Koutaro Takamatsu Yasuharu Nishimura Satoru Senju 《Human immunology》2013
Anticancer vaccination therapies with monocyte-derived dendritic cells (DC) are widely conducted. A large number of primary monocytes (approximately 108 cells) are needed to generate the number of DC required to achieve an effect upon vaccination, and monocytes are usually purified from peripheral blood mononuclear cells obtained by apheresis procedure, which is somehow invasive for cancer patients. As a means to facilitate the generation of DC for therapeutic use, we herein report a method to amplify human monocytes. We found that lentivirus-mediated transduction of cMYC along with BMI1 induced proliferation of CD14+ monocytes derived from 9 out of 12 blood donors, and we named the monocyte-derived proliferating cells CD14-ML. Their proliferation continued for 3–5 weeks in the presence of M-CSF and GM-CSF, resulting in 20–1000-fold amplification. Importantly, the expanded CD14-ML differentiated into fully functional DC (CD14-ML-DC) upon the addition of IL-4 to the culture. We successfully stimulated autologous CD8+ T cells with CD14-ML-DC pulsed with cytomegalovirus peptide or MART-1 peptide to generate antigen-specific CTL lines. This is the first report describing the method for in vitro expansion of human peripheral blood monocytes. 相似文献
147.
148.
Shota Yamamoto Tomohiro Matsumoto Satoshi Suda Kosuke Tomita Shunsuke Kamei Kazunobu Hashida Yutaka Imai Kazuyuki Endo Katsuki Murakami Terumitsu Hasebe 《The British journal of radiology》2021,94(1120)
Objective:We investigated the efficacy and exposure to radiation in 320-detector row computed tomography fluoroscopy-guided (CTF-guided) interventions.Methods:We analysed 231 320-detector row CTF-guided interventions (207 patients over 2 years and 6 months) in terms of technical success rates, clinical success rates, complications, scanner settings, overall radiation doses (dose–length product, mGy*cm), patient doses of peri-interventional CT series, and interventional CT (including CTF), as a retrospective cohort study. The relationships between patient radiation dose and interventional factors were assessed using multivariate analysis.Results:Overall technical success rate was 98.7% (228/231). The technical success rates of biopsies, drainages, and aspirations were 98.7% (154/156), 98.5% (66/67), and 100% (8/8), respectively. The clinical success rate of biopsies was 93.5% (146/156). All three major complications occurred in chest biopsies. The median total radiation dose was 522.4 (393.4–819.8) mGy*cm. Of the total radiation dose, 87% was applied during the pre- and post-interventional CT series. Post-interventional CT accounted for 24.4% of the total radiation dose. Only 11.4% of the dose was applied by CTF-guided intervention. Multilinear regression demonstrated that male sex, body mass index, drainage, intervention time, and helical scan as post-interventional CT were significantly associated with higher dose.Conclusion:The 320-detector row CTF interventions achieved a high success rate. Dose reduction in post-interventional CT provides patient dose reduction without decreasing the technical success rates.Advances in knowledge:This is the first study on the relationship between various interventional outcomes and patient exposure to radiation in 320-detector row CTF-guided interventions, suggesting a new perspective on dose reduction. 相似文献
149.
Takahiro Fuchigami Yutaka Sato Yuya Tomita Tetsuya Takano Shin‐ya Miyauchi Yukinori Tsuchiya Taro Saito Ken‐ichiro Kubo Kazunori Nakajima Mitsunori Fukuda Mitsuharu Hattori Shin‐ichi Hisanaga 《Genes to cells : devoted to molecular & cellular mechanisms》2013,18(5):410-424
Reelin‐Dab1 signaling is indispensable for proper positioning of neurons in mammalian brain. Reelin is a glycoprotein secreted from Cajal‐Reztuis cells in marginal zone of cerebral cortex, and its receptors are Apolipoprotein E receptor 2 (ApoER2) or very low density lipoprotein receptor (VLDLR) expressed on migrating neurons. When Reelin binds to ApoER2 or VLDLR, an adaptor protein Dab1 bound to the receptors undergoes Tyr phosphorylation that is essential for Reelin signaling. We reported previously that Cdk5‐p35 phosphorylates Dab1 at Ser400 and Ser491 and the phosphorylation regulates its binding to CIN85, which is an SH3‐containing multiadaptor protein involved in endocytic downregulation of receptor‐tyrosine kinases. However, the interaction of CIN85 with Dab1 has not been addressed in neurons. We examined here a possibility that CIN85 has a role in Reelin signaling. We found nonpho‐sphorylated Dab1‐mediated colocalization of CIN85 with ApoER2. The colocalization of CIN85 with ApoER2 was increased in neurons stimulated with Reelin repeats 3‐6, an active Reelin fragment. The stimulation recruited CIN85 to domains in plasma membrane where it colocalized with ApoER2 and Dab1 and then to EEA1‐labeled early endosomes in the cytoplasm. In addition, Tyr phosphorylation of Dab1 strengthened the binding to CIN85. These results suggest that CIN85 participates in Reelin signaling through the binding to Dab1. 相似文献